https://www.selleckchem.com/products/e-7386.html
Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 μl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 individuals (with longitudinal sampling) with
The New Zealand study visa opens doors to prestigious universities and exciting career prospects. Whether you're pursuing a degree or diploma, the application process is straightforward with the right guidance. Connect with us for expert advice. Email: contact@nzstudyadvisers.com, Phone: +91 7006455166.